A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
Clinical trial NCT06070610 · COMPLETED
Trial details
- NCT number
- NCT06070610
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2023-12-14
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.